C Trademark

Trademark Overview

On Tuesday, November 3, 2020, a trademark application was filed for C with the United States Patent and Trademark Office. The USPTO has given the C trademark a serial number of 90297134. The federal status of this trademark filing is REGISTERED as of Tuesday, March 8, 2022. This trademark is owned by Foresee Pharmaceuticals Co., Ltd.. The C trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, leuprolide mesylate injectable emulsion for the treatment of sex hormone-related diseases and disorders
c

General Information

Serial Number90297134
Word MarkC
Filing DateTuesday, November 3, 2020
Status700 - REGISTERED
Status DateTuesday, March 8, 2022
Registration Number6668202
Registration DateTuesday, March 8, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements

Description of MarkThe mark consists of a stylized letter "C" having two contiguous circular shapes within the center and to the right of the letter.
Goods and ServicesPharmaceutical preparations, namely, leuprolide mesylate injectable emulsion for the treatment of sex hormone-related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 5, 2021
Primary Code005
First Use Anywhere DateTuesday, December 21, 2021
First Use In Commerce DateTuesday, December 21, 2021

Trademark Owner History

Party NameForesee Pharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTaipei City 11501
TW
Party NameForesee Pharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTaipei City 11501
TW
Party NameForesee Pharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTaipei City 11501
TW

Trademark Events

Event DateEvent Description
Tuesday, March 8, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, February 2, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 1, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 21, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 4, 2022USE AMENDMENT FILED
Thursday, January 20, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 4, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 19, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, May 19, 2021ASSIGNED TO LIE
Wednesday, May 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 19, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, May 19, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 28, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 28, 2021FINAL REFUSAL E-MAILED
Wednesday, April 28, 2021FINAL REFUSAL WRITTEN
Friday, April 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 8, 2021NON-FINAL ACTION E-MAILED
Thursday, April 8, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 7, 2021ASSIGNED TO EXAMINER
Friday, February 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 19, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, February 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 6, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 6, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

hormone treatment related diseases disorders emulsion injectable preparations namely leuprolide